Stock Research for INCY

INCY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

INCY Stock Chart & Research Data

The INCY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the INCY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


INCY Due diligence Resources & Stock Charts

The INCY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View INCY Detailed Price Forecast - CNN Money CNN View INCY Detailed Summary - Google Finance
Yahoo View INCY Detailed Summary - Yahoo! Finance Zacks View INCY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View INCY Trends & Analysis - Trade-Ideas Barrons View INCY Major Holders - Barrons
NASDAQ View INCY Call Transcripts - NASDAQ Seeking View INCY Breaking News & Analysis - Seeking Alpha
Spotlight View INCY Annual Report - CompanySpotlight.com OTC Report View INCY OTC Short Report - OTCShortReport.com
TradeKing View INCY Fundamentals - TradeKing Charts View INCY SEC Filings - Bar Chart
WSJ View Historical Prices for INCY - The WSJ Morningstar View Performance/Total Return for INCY - Morningstar
MarketWatch View the Analyst Estimates for INCY - MarketWatch CNBC View the Earnings History for INCY - CNBC
StockMarketWatch View the INCY Earnings - StockMarketWatch MacroAxis View INCY Buy or Sell Recommendations - MacroAxis
Bullish View the INCY Bullish Patterns - American Bulls Short Pains View INCY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View INCY Stock Mentions - StockTwits PennyStocks View INCY Stock Mentions - PennyStockTweets
Twitter View INCY Stock Mentions - Twitter Invest Hub View INCY Investment Forum News - Investor Hub
Yahoo View INCY Stock Mentions - Yahoo! Message Board Seeking Alpha View INCY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for INCY - SECform4.com Insider Cow View Insider Transactions for INCY - Insider Cow
CNBC View INCY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for INCY - OTC Markets
Yahoo View Insider Transactions for INCY - Yahoo! Finance NASDAQ View Institutional Holdings for INCY - NASDAQ


Stock Charts

FinViz View INCY Stock Insight & Charts - FinViz.com StockCharts View INCY Investment Charts - StockCharts.com
BarChart View INCY Stock Overview & Charts - BarChart Trading View View INCY User Generated Charts - Trading View




Latest Financial News for INCY


Agenus Receives Milestone Payment of $5 Million from Incyte
Posted on Tuesday September 18, 2018

Agenus (AGEN) receives a milestone payment of $5 million from Incyte on the initiation of a phase I study of INCAGN2385.


See what the IHS Markit Score report has to say about Incyte Corp.
Posted on Saturday September 15, 2018

Incyte Corp NASDAQ/NGS:INCY


In Honor of MPN Awareness Day and Blood Cancer Awareness Month, Incyte Debuts Documentary Spotlighting Myeloproliferative Neoplasms (MPNs)
Posted on Thursday September 13, 2018

WILMINGTON, Del.-- -- Directed by an Academy Award ® winning filmmaker in the documentary short subject category, “Something So Rare” chronicles the lives of four people living with MPNs, rare blood cancers MPN community encouraged to access new resources and participate in awareness initiatives in support of MPN Awareness Day Today on MPN Awareness Day and throughout September, Blood Cancer Awareness ...


Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
Posted on Thursday September 13, 2018

WILMINGTON, Del.-- -- Study met primary and key secondary endpoints, demonstrating significant improvement from baseline in EASI score and reduced itch compared to vehicle Results presented at EADV support planned initiation of global, pivotal Phase 3 program Incyte Corporation today announced positive results from its randomized, dose-ranging, vehicle- and active-controlled Phase 2b study evaluating ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.